(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate

C56H58N8O11 — CID 155177423

IUPAC(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate
SMILESCCNC(=O)c1nnc(-c2cc(C(C)C)c(O)cc2O)n1-c1ccc(Oc2ccc(C(O)N3CCC(N(C)C(=O)Oc4ccc5nc6c(c(CC)c5c4)Cn4c-6cc5c(c4=O)COC(=O)C5(O)CC)CC3)cc2)cc1
InChIInChI=1S/C56H58N8O11/c1-7-37-39-24-36(18-19-44(39)58-48-41(37)28-63-45(48)26-43-42(53(63)69)29-73-54(70)56(43,72)8-2)75-55(71)61(6)32-20-22-62(23-21-32)52(68)31-10-14-34(15-11-31)74-35-16-12-33(13-17-35)64-49(59-60-50(64)51(67)57-9-3)40-25-38(30(4)5)46(65)27-47(40)66/h10-19,24-27,30,32,52,65-66,68,72H,7-9,20-23,28-29H2,1-6H3,(H,57,67)
InChIKeyUFGVGORXDNFEKN-UHFFFAOYSA-N
MW1019.12 g/mol
LogP7.55
Rot. Bonds13

About (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate

(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate (PubChem CID 155177423) has the molecular formula C56H58N8O11 and a molecular weight of 1019.12 g/mol. Its IUPAC name is (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate.

Molecular Properties

Compound Name(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate
PubChem CID155177423
Molecular FormulaC56H58N8O11
Molecular Weight1019.12 g/mol
Exact Mass1018.42
IUPAC Name(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate
SMILESCCNC(=O)c1nnc(-c2cc(C(C)C)c(O)cc2O)n1-c1ccc(Oc2ccc(C(O)N3CCC(N(C)C(=O)Oc4ccc5nc6c(c(CC)c5c4)Cn4c-6cc5c(c4=O)COC(=O)C5(O)CC)CC3)cc2)cc1
InChIInChI=1S/C56H58N8O11/c1-7-37-39-24-36(18-19-44(39)58-48-41(37)28-63-45(48)26-43-42(53(63)69)29-73-54(70)56(43,72)8-2)75-55(71)61(6)32-20-22-62(23-21-32)52(68)31-10-14-34(15-11-31)74-35-16-12-33(13-17-35)64-49(59-60-50(64)51(67)57-9-3)40-25-38(30(4)5)46(65)27-47(40)66/h10-19,24-27,30,32,52,65-66,68,72H,7-9,20-23,28-29H2,1-6H3,(H,57,67)
InChIKeyUFGVGORXDNFEKN-UHFFFAOYSA-N
XLogP7.55
TPSA243.93 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds13
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001019.12
LogP ≤ 57.55
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Analyze (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate?
The IUPAC name of (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate (CID 155177423) is (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate.
What is the SMILES notation for (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate?
The canonical SMILES for (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate is CCNC(=O)c1nnc(-c2cc(C(C)C)c(O)cc2O)n1-c1ccc(Oc2ccc(C(O)N3CCC(N(C)C(=O)Oc4ccc5nc6c(c(CC)c5c4)Cn4c-6cc5c(c4=O)COC(=O)C5(O)CC)CC3)cc2)cc1.
What is the InChIKey of (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate?
The InChIKey is UFGVGORXDNFEKN-UHFFFAOYSA-N. The full InChI is InChI=1S/C56H58N8O11/c1-7-37-39-24-36(18-19-44(39)58-48-41(37)28-63-45(48)26-43-42(53(63)69)29-73-54(70)56(43,72)8-2)75-55(71)61(6)32-20-22-62(23-21-32)52(68)31-10-14-34(15-11-31)74-35-16-12-33(13-17-35)64-49(59-60-50(64)51(67)57-9-3)40-25-38(30(4)5)46(65)27-47(40)66/h10-19,24-27,30,32,52,65-66,68,72H,7-9,20-23,28-29H2,1-6H3,(H,57,67).
What are the key properties of (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate?
(10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate has a molecular weight of 1019.12 g/mol, XLogP of 7.55, 13 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) N-[1-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]phenyl]-hydroxymethyl]piperidin-4-yl]-N-methylcarbamate is sourced from PubChem (CID 155177423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).